This Article Full Text Full Text (PDF) All Versions of this Article: 144/7/2761    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levasseur, R. Articles by Karsenty, G. Search for Related Content PubMed PubMed Citation Articles by Levasseur, R. Articles by Karsenty, G. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLCYSTEINE CYSTEINE

Reversible Skeletal Abnormalities in -Glutamyl Transpeptidase-Deficient Mice

Departments of Molecular and Human Genetics (R.L., F.E., D.G., G.K.) and Pathology (R.B., M.W.L.), M.D./Ph.D. Program (D.G.), Baylor College of Medicine, Houston, Texas 77030

Address all correspondence and requests for reprints to: Gerard Karsenty, M.D., Ph.D., Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030. E-mail: karsenty{at}bcm.tmc.edu.

-Glutamyl transpeptidase (GGT) is a widely distributed ectopeptidase responsible for the degradation of glutathione in the -glutamyl cycle. This cycle is implicated in the metabolism of cysteine, and absence of GGT causes a severe intracellular decrease in this amino acid. GGT-deficient (GGT-/-) mice have multiple metabolic abnormalities and are dwarf. We show here that this latter phenotype is due to a decreased of the growth plate cartilage total height resulting from a proliferative defect of chondrocytes. In addition, analysis of vertebrae and tibiae of GGT-/- mice revealed a severe osteopenia. Histomorphometric studies showed that this low bone mass phenotype results from an increased osteoclast number and activity as well as from a marked decrease in osteoblast activity. Interestingly, neither osteoblasts, osteoclasts, nor chondrocytes express GGT, suggesting that the observed defects are secondary to other abnormalities. N-acetylcysteine supplementation has been shown to reverse the metabolic abnormalities of the GGT-/- mice and in particular to restore the level of IGF-1 and sex steroids in these mice. Consistent with these previous observations, N-acetylcysteine treatment of GGT-/- mice ameliorates their skeletal abnormalities by normalizing chondrocytes proliferation and osteoblastic function. In contrast, resorbtion parameters are only partially normalized in GGT-/- N-acetylcysteine-treated mice, suggesting that GGT regulates osteoclast biology at least partly independently of these hormones. These results establish the importance of cysteine metabolism for the regulation of bone remodeling and longitudinal growth.

This article has been cited by other articles:

				K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice Am. J. Pathol., February 1, 2008; 172(2): 440 - 453. [Abstract] [Full Text] [PDF]

				M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting beta-Catenin from T Cell Factor- to Forkhead Box O-mediated Transcription J. Biol. Chem., September 14, 2007; 282(37): 27298 - 27305. [Abstract] [Full Text] [PDF]

				K. Hiramatsu, Y. Asaba, S. Takeshita, Y. Nimura, S. Tatsumi, N. Katagiri, S. Niida, T. Nakajima, S. Tanaka, M. Ito, et al. Overexpression of {gamma}-Glutamyltransferase in Transgenic Mice Accelerates Bone Resorption and Causes Osteoporosis Endocrinology, June 1, 2007; 148(6): 2708 - 2715. [Abstract] [Full Text] [PDF]

				S. Niida, M. Kawahara, Y. Ishizuka, Y. Ikeda, T. Kondo, T. Hibi, Y. Suzuki, K. Ikeda, and N. Taniguchi {gamma}-Glutamyltranspeptidase Stimulates Receptor Activator of Nuclear Factor-{kappa}B Ligand Expression Independent of Its Enzymatic Activity and Serves as a Pathological Bone-resorbing Factor J. Biol. Chem., February 13, 2004; 279(7): 5752 - 5756. [Abstract] [Full Text] [PDF]